IP Library Granted Patent US 7,094,420
Granted Patent B2
US 7,094,420 · App. 09/949,458 · Granted Aug 22, 2006

Methods of using isomer enriched conjugated linoleic acid compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,094,420
App. No.
09/949,458
Granted
Aug 22, 2006
Kind
B2
Abstract

Compositions and methods of using conjugated linoleic acid preparations enriched for the t10,c12 and c9,t11 isomers are disclosed. It is found that preparations of conjugated linoleic acid containing a ratio of t10,c12 to c9,t11 of about greater than 1.2:1 are desirable for a wide variety of nutritional, therapeutic and pharmacologic uses.

Claims (12)

1. A method of reducing body fat in animals comprising:

providing an animal a conjugated linoleic acid preparation enriched for the t10,c12 isomer;

administering said conjugated linoleic acid isomer preparation to said animal so that body fat is reduced, wherein said conjugated linoleic acid preparation is characterized in containing 10,12-conjugated linoleic acid and 9,11-conjugated linoleic acid in a ratio greater than 1.2:1.

2. The method of claim 1 , wherein said conjugated linoleic acid composition is at least approximately 80% t10,c12 octadecadienoic acid.

3. The method of claim 1 , wherein said conjugated linoleic acid composition is at least approximately 92% t10,c12 octadecadienoic acid.

4. The method of claim 1 , wherein said conjugated linoleic acid preparation is provided as a preparation selected from the group consisting of free fatty acids, alkylesters and triglycerides.

5. A method of treating obesity in humans comprising:

providing a patient suffering from obesity an enriched t10,c12 conjugated linoleic acid preparation;

administering said conjugated linoleic acid isomer preparation to said patient so that body fat is reduced, wherein said conjugated linoleic acid preparation is characterized in containing 10,12-conjugated linoleic acid and 9,11-conjugated linoleic acid in a ratio greater than 1.2:1.

6. The method of claim 5 , wherein said conjugated linoleic acid composition is at least approximately 80% t10,c12 octadecadienoic acid.

7. The method of claim 5 , wherein said conjugated linoleic acid composition is at least approximately 92% t10,c12 octadecadienoic acid.

8. The method of claim 5 , wherein said conjugated linoleic acid is provided as a preparation selected from the group consisting of free fatty acids, alkylesters and triglycerides.

Assignments (4)
CHANGE OF NAME Recorded Sep 7, 2007
From: NATURAL ASA
To: AKER BIOMARINE ASA
Reel/Frame 019805/0274 →
CHANGE OF NAME Recorded Sep 7, 2007
From: NATURAL ASA
To: AKER BIOMARINE ASA
Reel/Frame 019805/0418 →
RE-RECORD TO CORRECT THE ADDRESS OF THE ASSIGNEE. Recorded Feb 3, 2006
From: NATURAL CORPORATION
To: NATURAL ASA
Reel/Frame 017240/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2002
From: CONLINCO., INC.
To: NATURAL CORPORATION
Reel/Frame 012928/0844 →